Skip to content

How to Tell If a GLP-1 Price Comparison Is Trustworthy

A dated method for reading any GLP-1 provider comparison, including ours: who wrote it, when each price was read, and who is paid for the placement.

By PeptidesBeat Editorial Desk

Last reviewed

A GLP-1 provider comparison is trustworthy when it answers five questions on the page itself: who wrote it, who is paid when you click, when each price was read, how it was verified, and whether the page’s own price was held to the same standard as the prices it compares. On September 20, 2026 we fetched eleven of the provider-comparison pages now competing for GLP-1 pricing queries, read their method notes line by line, and then ran the same five questions over our own GLP-1 pricing hub. Most of those pages answer two or three. This page is the test, written out, so you can run it on ours.

The advertised price is a starting point, not a bill

The number in a comparison page’s headline is usually one component of a multi-part bill. Four things routinely move it after you enrol.

A membership or program fee billed beside the medication. Our own provider table prints the split in the row itself: Hims & Hers appears as “Membership $39 first mo, then $149/mo — meds NOT included” (GLP-1 pricing hub). One vendor comparison page describes the same structure at a low-cost competitor in its own words: Eden’s “membership fees ($39 first month, $99 ongoing)” and its medication prices “$99 semaglutide, $199 tirzepatide” (PlexusDx, Eden hidden fees).

A medication price that steps up with the dose. The batch of pages we read contains 38 separate pages about dose pricing alone — titles like “Fridays Health GLP-1 Dose Pricing: What Happens When You Titrate Up” (PlexusDx). Not every provider publishes a stable monthly medication price to step up from: on its Sesame Care page the same vendor writes that “Sesame Care 12-month totals cannot be calculated because no stable monthly medication price was published” (PlexusDx, Sesame Care dose pricing). If the page you are reading can compile a 12-month total for one provider and not for another, that difference is information.

Labs, shipping and visits — bundled, itemized, or unmentioned. A price can be all-in, or it can be three charges that a comparison page never lists. The Eden page is unusually direct about the limit of what it could see: “No separate line-item fees for visits, labs, or shipping were observed; we infer those services are bundled into the membership, but the itemization was not published in the materials we reviewed” (PlexusDx). “We infer” is a stronger disclosure than a silent omission, and it tells you the number in the table is inferred rather than read.

Cancellation terms and minimum commitments. Billing after the first month, and how hard it is to stop, are part of the cost — and in the US they are also a regulatory subject. The FTC, joined by Utah and California, alleged in a complaint filed July 29, 2026 that Hims & Hers “fails to clearly disclose that it charges consumers for prescriptions almost immediately after they submit an intake form” and “has made it difficult for consumers to cancel subscriptions” (FTC press release). That is an allegation in a pending case, not a finding; Hims & Hers disputes it. The point for a price reader is narrower: what a program charges in month one and what it charges in month nine are different questions, and a comparison page that answers only the first has answered half of it.

Which channel you buy through changes the number again — insured, Medicare, manufacturer cash-pay, compounded, or list — which is why the same molecule can appear as five different monthly figures in one article (coverage gap).

How do I tell if a GLP-1 price comparison is trustworthy?

Ask the five questions below, in order, of the page in front of you — vendor-owned, affiliate-monetised, or ours. A page passes when you can answer all five without leaving it.

1. Who wrote it, and who is paid when you click?

Both answers belong on the page. We found two opposite shapes.

Disclosed. The affiliate rankings site weightlossrankings.org states in its own about page that “Weight Loss Rankings makes money through affiliate commissions” and, in its disclosure, “Score is independent. Placement is not always.” — then names what can be bought: featured placements, “Top Pick” labels, homepage callouts, blog coverage frequency. We read those two pages through an Internet Archive capture of August 27, 2026, because the live site returned HTTP 429 to our fetch. That is a page telling you exactly how to discount it, which is the useful version.

Byline-as-seller. Every one of the eleven vendor comparison pages we fetched carries the same byline — “Written by: Jay Hastings, CEO of PlexusDx” — on the same site that sells the program being ranked first (example). That does not make the numbers wrong; it tells you what the page’s incentives are, which is what a disclosure is for.

2. Is the page’s own price the freshest number in its own table?

This is the single most useful thing to check, because it is arithmetic, not judgement. Take the seven pages in the batch that compare a named brand or telehealth provider against a set of low-cost competitors. On the Calibrate page, the method note says:

“We captured Calibrate’s program pricing from joincalibrate.com/lp/pricing1 on September 4, 2026. PlexusDx pricing was captured from our canonical pricing source on September 19, 2026. Low-cost provider pricing (Eden, Embody, Found, Henry Meds, Peak Wellness, TrimRx) was checkout-verified July 17–23, 2026, from each provider’s website.”

The page was published on September 19, 2026, and says so in its own JSON-LD. So on that page: the author’s own price is same-day, and the six competitors it is measured against were captured 58 to 64 days earlier.

The same batch does not apply one rule, which is why you read the page and not the batch. The Henry Meds and Found pages stamp the seller’s own pricing in that same July 17–23 window, and the Rift page goes further and says outright that its own figure is not first-party: “PlexusDx pricing reflects institutional knowledge current as of September 2026 and aligns with figures published on a third-party comparison chart captured July 17–23, 2026” (PlexusDx vs Rift). A comparison in which one column is right and the other is eight weeks old can still be honest — but only if you can see which column is which.

3. Does it date each figure, or only the article?

An article-level “last updated” date does not tell you which numbers moved. The device that does is a per-row read date under a dated column header. Our own oral-GLP-1 provider table prints exactly that — “Monthly price (observed Aug 29, 2026)” across the top, a “Reporting week (as of)” and a “Source” column down the side, and the rule stated in the body: “Each row states the week it was read from; figures from different editions are never combined in one sentence on this page” (oral GLP-1 comparison). The same page closes with a “What the data cannot settle — read these limits before quoting the numbers” block. Two of those three devices are cheap to copy and almost nobody copies them.

4. Does the method note say how, not just when?

“Captured July 17–23” and “checkout-verified July 17–23” are different claims, and so are “captured from our canonical pricing source”, “institutional knowledge”, and “internal pricing structures”. The batch we read uses all of them, including this one: “PlexusDx pricing is current as of September 14, 2026, and drawn from internal pricing structures” (ReflexMD page). Read the verb. A price read off a public page, a price produced by walking a checkout, and a price supplied by the company that is being priced are three different levels of evidence.

5. Where does the author’s own product sit in the ranking?

A page titled “PlexusDx vs Rift: GLP-1 Pricing & Plan Terms Compared in 2026” puts the publisher in the comparison. On that page the note says Rift’s website was reviewed and “no public pricing, product itemization, or contract terms were located”. The honest question to ask of any such page, vendor or affiliate: what would this page have to publish to come out unfavourable to the party that pays for it? If you cannot construct the answer, treat the ranking as advertising.

Our method for this page

Every fact above was read from the pages themselves on the dates below. Last verified: September 20, 2026.

What we readRead (as of)How it was verified
Eleven PlexusDx comparison pages, including their “Methodology and freshness” notes and their JSON-LD date stampsSeptember 20, 2026Each URL fetched and saved in full, then read from those saved bytes; the quotes above are copied from the page text
The batch totals and dates (232 pages with the same slug pattern, published 2026-09-14 to 2026-09-19, 230 of them stamped modified within four seconds of published)September 20, 2026Read from each page’s own JSON-LD; we fetched eleven of the 232 again today
The FTC languageSeptember 20, 2026The FTC press release, fetched in full; quoted as an allegation in a pending case
weightlossrankings.org about and disclosure pagesAugust 27, 2026 (capture)The live site returned HTTP 429 to our fetch; read through the Internet Archive capture instead
Our own pricing hub, oral comparison, checklist, editorial policy and directory pagesSeptember 20, 2026Fetched from production and read from the served bytes, not from our source files

What this page cannot settle. We did not verify any provider’s price at checkout; where a figure appears here it is what a page says, on the date that page states. No Google search-results page was available to us, so nothing here should be read as a ranking claim. Three affiliate comparison domains refused our fetches outright (HTTP 429) and we did not characterise them. The 232-page count is our own census, not an independently audited figure.

Hold this page to the same standard. If you find a price here that is older than a competitor’s on the same page, a figure with no read date, or a claim about a provider that its own page does not support, we failed our own test — tell us and we will date the figure or pull it.

Where our own pages fail this test today

A test that only catches other people’s pages is not a test. One failure of ours is still open, and one was closed today. Both dated:

Our pricing hub’s method sentence said “Every price below is a ‘starting at’ figure observed on provider pages August 29, 2026”, and two of its nine rows did not meet it: the Found and PlushCare figures come from a third-party page the hub itself dates “updated Jul 17, 2026”, 43 days before the date that sentence gave for every row. Corrected September 20, 2026: the sentence now names the seven rows read from the providers’ own pricing pages and the two that are not, the column header reads “unless noted”, and both rows carry the label in their own Caveats cell (pricing hub).

Our compounding pharmacy checklist carries no published or modified date at all, so a reader checking how fresh it is has nothing to check against. It is the page we send readers to for the verification half of the question, which is exactly why it should be dated. Corrected September 20, 2026: this paragraph previously reported that the checklist’s served bytes contained eight literal escape sequences where a dash belongs. Those escapes have been replaced with real dashes, so that defect is closed; the missing publish or modified date is not, and stays open.

Who pays for this page

We state this in the body rather than only in the footer, because the footer line is not visible to someone scanning a table.

What we sell: subscriber revenue from our daily brief, educational products, research reports, and flat-fee pharmacy and prescriber directory listings — $79 / $149 / $299 per month covering listing depth, with “Position in the directory is editorial and not affected by tier” (directory).

What we will not make money from, ever: “Affiliate commissions from compounding pharmacies on prescription fills. Sponsored content from peptide-selling telehealth brands. Pay-for-placement in our directory. Programmatic display advertising networks” (editorial policy).

There are no affiliate links on this page. We link to provider pages only to quote what they say; a link here is a citation, not a referral, and earns us nothing.

Frequently asked questions

How do I tell if a GLP-1 price comparison is trustworthy?

Check five things on the page itself: who wrote it, whether it discloses affiliate or sponsorship revenue, whether each figure carries its own read date, whether the method note says how the price was captured, and whether the page’s own price is the freshest number in its own table. A page that answers all five lets you discount its incentives and use its numbers. A page that answers none is a starting point for a price, not a source for one.

Why is the GLP-1 price I am advertised lower than what I am billed?

Because the advertised number is usually one component of a multi-part bill. Common splits: a membership or program fee billed beside the medication; a medication price that steps up as the dose increases; lab work, shipping and follow-up visits that are bundled, itemized, or not published at all; and minimum terms or cancellation terms. Compare the total over 12 months, not the monthly headline.

Does PeptidesBeat publish GLP-1 provider comparisons?

One dated provider price table and this method page. We do not run a programmatic comparison programme and we have not published a set of provider-versus-provider pages. Where this page names a provider, it is to quote that provider’s own page, not to rank it against another.

Sources

This article is for informational purposes only and is not medical advice. Prices quoted from provider pages are “starting at” figures as published on the dates stated, and can change at any time.


Educational content, not medical advice. © 2026 PeptidesBeat.